AstraZeneca Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Buy" and an average price target of $213.89. The average 1-year stock price forecast is 26.37% higher than the current stock price, while the lowest is $184 (+8.71%) and the highest is $240 (+41.79%).

Price Target: $213.89 (+26.37%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$184	$213.89	$213.5	$240
Change	+8.71%	+26.37%	+26.14%	+41.79%

Analyst Ratings

The average analyst rating for AstraZeneca stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	6	6	7	7	7	6
Buy	2	2	2	2	2	2
Hold	0	1	1	1	1	2
Sell	1	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Leuchten Jefferies	Jefferies	Buy Maintains $233	Buy	Maintains	$233	+37.72%	Jul 22, 2026
Richard Vosser J.P. Morgan	J.P. Morgan	Buy Maintains $165 → $213	Buy	Maintains	$165 → $213	+25.91%	Jul 21, 2026
Sarita Kapila Morgan Stanley	Morgan Stanley	Buy Maintains $220 → $204	Buy	Maintains	$220 → $204	+20.41%	Jul 16, 2026
Emmanuel Papadakis Deutsche Bank	Deutsche Bank	Sell Maintains $153	Sell	Maintains	$153	-9.50%	Jul 15, 2026
Rajesh Kumar HSBC	HSBC	Hold Downgrades $183	Hold	Downgrades	$183	+8.21%	Jul 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

63.21B

from 58.74B

7.62%

from 58.74B

Revenue Next Year

66.79B

from 63.21B

5.66%

from 63.21B

EPS This Year

10.25

from 9.16

11.94%

from 9.16

EPS Next Year

11.51

from 10.25

12.25%

from 10.25

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	37.42B	44.35B	45.81B	54.07B	58.74B	63.21B
Revenue Growth	40.58%	18.53%	3.29%	18.04%	8.63%	7.62%
Gross Profit	25.41B	35.71B	37.77B	44.44B	47.99B	52.45B
Gross Margin	67.92%	80.52%	82.44%	82.18%	81.71%	82.98%
Operating Income	2.90B	8.81B	9.70B	12.93B	14.29B	21.14B
Net Income	112.00M	3.29B	5.96B	7.04B	10.23B	12.43B
EPS	-	-	-	-	9.16	10.25
EPS Growth	-	-	-	-	11.57%	11.94%
Forward PE	-	-	-	-	-	16.51
Dividend / Share	2.87	2.90	2.90	3.10	3.20	3.34
Dividend Growth	-	1.05%	-	6.90%	3.23%	4.39%
Free Cash Flow	-1.85B	12.49B	9.04B	8.46B	7.87B	10.04B
No. Analysts	-	-	-	-	-	24

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	64.5B
Avg	63.2B
Low	58.6B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	9.8%
Avg	7.6%
Low	-0.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	10.71
Avg	10.25
Low	10.01

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	16.9%
Avg	11.9%
Low	9.2%